Ypsomed examines investment options

Press Releases Ypsomed Group

Burgdorf – At the general meeting of 27 June 2012 Ypsomed shareholders approved the growth strategy.

En savoir plus...

Ypsomed recruits expertise to grow diabetes care business

Press Releases Ypsomed Group

Burgdorf – Ypsomed has recruited two experienced diabetes care executives to boost its diabetes treatment product franchise.

En savoir plus...

Ypsomed 2011/12 business year

Press Releases Ypsomed Group

Burgdorf – In the past 2011/12 business year, the Ypsomed Group increased net profit by 55.5% to CHF 8.5 million, which was positively affected by the sale of financial assets.

En savoir plus...

Ypsomed launches new commercial product mylife DailyDose

Press Releases Ypsomed Group

Burgdorf – Ypsomed is expanding its mylife product range with the innovative self-injection system mylife DailyDose.

En savoir plus...

Sanofi-Aventis reacts to Ypsomed patent lawsuit

Press Releases Ypsomed Group

Burgdorf - SYpsomed has taken notice that Sanofi-Aventis has filed a lawsuit in Basel against Ypsomed AG and TecPharma Licensing AG in relation to the SoloStar injection system developed and manufactured by Sanofi-Aventis. The lawsuit claims certain license rights, which in the opinion of Sanofi-Aventis should be granted by Ypsomed.

En savoir plus...